NIH foun­da­tion taps top Mer­ck ex­ec — and oft-cit­ed woman of the year — Julie Ger­berd­ing to steer pub­lic-pri­vate R&D ini­tia­tive

The Foun­da­tion for the NIH has turned to a promi­nent Big Phar­ma ex­ec to take the helm, where she will take charge of some key pub­lic-pri­vate re­search part­ner­ships with in­dus­try. And she comes with a blue chip ré­sumé for her in­volve­ment in some ma­jor pub­lic health ini­tia­tives over the decade.

For­mer CDC di­rec­tor, for­mer Mer­ck vac­cines chief and cur­rent chief pa­tient of­fi­cer Julie Ger­berd­ing has been tapped for the lead po­si­tion at the FNIH, which played a sig­nif­i­cant sup­port role in de­vel­op­ing vac­cines and ther­a­pies for Covid-19. And the foun­da­tion ap­pears to be on the verge of gain­ing a big­ger — much big­ger — al­lo­ca­tion for its work steer­ing some of the top pub­lic-pri­vate al­liances in drug and vac­cine de­vel­op­ment.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER